Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007450
Abstract: Toxic activation of immune cells can lead to life-threatening conditions, all previously named hemophagocytic lymphohistiocytosis (HLH). Increased knowledge of the etiology and various underlying pathologies deems new nomenclature necessary. 1 HLH and HLH mimicries are… read more here.
Keywords: mimic disease; disease based; havcr2 variants; treatment hlh ... See more keywords